EUVIMEDEUVIMED entdecken
Crossref

In-vitro and in-silico anti-HSV-1 activity of a marine steroid from the jellyfish Cassiopea andromeda venom

Shakib Shamsian, Iraj Nabipour, Gholamhossein Mohebbi, Neda Baghban, Masoud Zare, Keivan Zandi, Amir Vazirizadeh, Ammar Maryamabadi, Cédric Delattre

Microbial Pathogenesis · 2024

DOI: 10.1016/j.micpath.2023.106486 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbial Pathogenesis, 2024. Verfasst von Shakib Shamsian und 8 weiteren Autor:innen. Beteiligte Einrichtung: The Persian Gulf Marine Biotechnology Research Center, The Persian Gulf Biomedical Sciences Research Institute, Bushehr University of Medical Science…. Hauptthemen laut MEDLINE: Herpesvirus 1, Human, Cnidarian Venoms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 76 Literaturangaben. Gefördert von: Bushehr University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this study, we investigated the potential in vitro anti-HSV-1 activities of the Cassiopea andromeda jellyfish tentacle extract (TE) and its fractions, as well as computational work on the thymidine kinase (TK) inhibitory activity of the identified secondary metabolites. The LD50, secondary metabolite identification, preparative and analytical chromatography, and in silico TK assessment were performed using the Spearman-Karber, GC-MS, silica gel column chromatography, RP-HPLC, LC-MS, and docking methods, respectively. The antiviral activity of TE and the two purified compounds Ca2 and Ca7 against HSV-1 in Vero cells was evaluated by MTT and RT-PCR assays. The LD50 (IV, mouse) values of TE, Ca2, and Ca7 were 104.0 ± 4, 5120 ± 14, and 197.0 ± 7 (μg/kg), respectively. They exhibited extremely effective antiviral activity against HSV-1. The CC50 and MNTD of TE, Ca2, and Ca7 were (125, 62.5), (25, 12.5), and (50, 3.125) μg/ml, respectively. GC-MS analysis of the tentacle extract revealed seven structurally distinct chemical compositions. Four of the seven compounds had a steroid structure. According to the docking results, all compounds showed binding affinity to the active sites of both thymidine kinase chains. Among them, the steroid compound Pregn-5-ene-3,11-dione, 17,20:20,21 bis [methylenebis(oxy)]-, cyclic 3-(1,2-ethane diyl acetal) (Ca2) exhibited the highest affinity for both enzyme chains, surpassing that of standard acyclovir. In silico data confirmed the experimental results. We conclude that the oxosteroid Ca2 may act as a potent agent against HSV-1.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Herpesvirus 1, HumanCnidarian VenomsChlorocebus aethiopsAnimalsMiceAntiviral AgentsVero CellsThymidine KinaseSteroids

Stichwörter der Autor:innen

Cassiopea andromedaDockingSecondary metaboliteThymidine kinaseanti-HSV-1

Substanzen

Antiviral AgentsThymidine KinaseCnidarian VenomsSteroids

Autor:innen und Institutionen

  • The Persian Gulf Marine Biotechnology Research Center, The Persian Gulf Biomedical Sciences Research Institute, Bushehr University of Medical Sciences, Bushehr, Iran. Electronic address: shakib_shamsiyan@yahoo.com.
  • The Persian Gulf Marine Biotechnology Research Center, The Persian Gulf Biomedical Sciences Research Institute, Bushehr University of Medical Sciences, Bushehr, Iran. Electronic address: inabipour@gmail.com.
  • The Persian Gulf Marine Biotechnology Research Center, The Persian Gulf Biomedical Sciences Research Institute, Bushehr University of Medical Sciences, Bushehr, Iran. Electronic address: Mohebbihsn@yahoo.com.
  • The Persian Gulf Marine Biotechnology Research Center, The Persian Gulf Biomedical Sciences Research Institute, Bushehr University of Medical Sciences, Bushehr, Iran. Electronic address: neda.bagban@gmail.com.
  • The Persian Gulf Marine Biotechnology Research Center, The Persian Gulf Biomedical Sciences Research Institute, Bushehr University of Medical Sciences, Bushehr, Iran. Electronic address: md.zare77@gmail.com.
  • Tropical Infectious Diseases Research and Education Center (TIDREC), University of Malaya, Kuala Lumpur, Malaysia. Electronic address: keivanzandi@yahoo.com.

Förderung

  • Bushehr University of Medical Sciences

Zitieren

APA

Shamsian, S., Nabipour, I., Mohebbi, G., Baghban, N., Zare, M., Zandi, K., Vazirizadeh, A., Maryamabadi, A., & Delattre, C. (2024). In-vitro and in-silico anti-HSV-1 activity of a marine steroid from the jellyfish Cassiopea andromeda venom. Microbial Pathogenesis. https://doi.org/10.1016/j.micpath.2023.106486

Vancouver

Shamsian S, Nabipour I, Mohebbi G, Baghban N, Zare M, Zandi K, et al. In-vitro and in-silico anti-HSV-1 activity of a marine steroid from the jellyfish Cassiopea andromeda venom. Microbial Pathogenesis. 2024. doi:10.1016/j.micpath.2023.106486

BibTeX
@article{Shamsian2024,
  author = {Shamsian, Shakib and Nabipour, Iraj and Mohebbi, Gholamhossein and Baghban, Neda and Zare, Masoud and Zandi, Keivan and Vazirizadeh, Amir and Maryamabadi, Ammar and Delattre, Cédric},
  title = {In-vitro and in-silico anti-HSV-1 activity of a marine steroid from the jellyfish Cassiopea andromeda venom},
  journal = {Microbial Pathogenesis},
  year = {2024},
  doi = {10.1016/j.micpath.2023.106486}
}
Kostenlos starten →